The signaling pathway of epidermal growth factor receptor (EGFR), a cell membrane bound tyrosine kinase, plays an important role in breast cancer progression and regulates cell metabolism through kinasedependent and -independent mechanism. Additionally, accumulated evidence has demonstrated the close relationship between cancer progression and energy metabolism. Metabolic deregulation has even lately been considered as the seventh hallmark of cancers in addition to the well-established six hallmarks. Recently, we have demonstrated that EGFR, independent of its kinase activity, maintains the basal intracellular glucose level by associating with and stabilizing a sodium/glucose cotransporter (SGLT1), thereby preventing cells from undergoing autophagic death. The resulL together with those reported in the literature that AKT may activate another glucose transporter, GLLIT4 to enhance energy metabolism had stimulated us to hypothesize that EGFR may mediate glucose uptake through both tyrosine kinase dependent and independent pathways, which may contribute to the EGFR-mediated malignant phenotype in breast cancer cells. In addition, we and others have also shown that cell surface receptor-mediated kinases including ERK, AKT and IKK regulate TSC1/TSC2 complex and FoxoSa, both of which are known to involve in tumor progression and energy balance. These three kinases are frequently activated in human cancers including breast cancer and have served as therapeutic targets for the development on anti-cancer drugs. The long-term goal of this proposal is to understand molecular mechanism of breast cancer progression and metabolic regulation. Specifically, in the current proposal we propose three Specific Aims to fulfill the goals:
Specific Aim 1 : To elucidate the role of kinase-independent EGFR mediated glucose transporter signaling in mammary tumor progression.
Specific Aim 2 : To investigate energy metabolism regulated by the kinase-dependent EGFR signaling pathways.
Specific Aim 3 : To determine the role of kinase-dependent EGFR signaling in mammary tumor progression. The outcome of this project will advance an understanding on the effect of glucose metabolism on breast cancer progression and may shed light on new directions for breast cancer therapy.

Public Health Relevance

Through both kinase-dependent and -independent mechanisms, the epidermal growth factor receptor plays an important role in breast cancer progression and metabolism. This project will be focused on understanding those mechanisms as they relate to glucose transporter signaling, energy metabolism, and mammary tumor progression. Success of this project may shed light on new directions for breast cancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA099031-08
Application #
8381356
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$517,358
Indirect Cost
$339,767
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yamaguchi, H; Du, Y; Nakai, K et al. (2018) EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene 37:208-217
Joshi, Sonali; Yang, Jun; Wang, Qingfei et al. (2017) 14-3-3? loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling. Am J Cancer Res 7:1654-1664
Hsu, Ming-Chuan; Hung, Wen-Chun; Yamaguchi, Hirohito et al. (2016) Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. Am J Cancer Res 6:628-38
Acharya, Sunil; Xu, Jia; Wang, Xiao et al. (2016) Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib. Am J Cancer Res 6:981-95
Chen, Mei-Kuang; Hung, Mien-Chie (2016) Regulation of therapeutic resistance in cancers by receptor tyrosine kinases. Am J Cancer Res 6:827-42
Boulay, Pierre-Luc; Mitchell, Louise; Turpin, Jason et al. (2016) Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression. Cancer Res 76:2662-74
Mazumdar, Abhijit; Poage, Graham M; Shepherd, Jonathan et al. (2016) Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast Cancer Res Treat 158:441-54
Haukaas, Tonje H; Euceda, Leslie R; Giskeødegård, Guro F et al. (2016) Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer Metab 4:12
Lim, Seung-Oe; Li, Chia-Wei; Xia, Weiya et al. (2016) EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. Cancer Res 76:1284-96
Ko, How-Wen; Lee, Heng-Huan; Huo, Longfei et al. (2016) GSK3? inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. Oncotarget 7:57131-57144

Showing the most recent 10 out of 204 publications